AZBio Board of Directors

Michael Ash

Senior Vice President

Head of the Skeletal Conditions Business Unit

BioMarin Pharmaceuticals

                                      

 

Michael Ash is an accomplished biotechnology executive with over three decades of experience in rare disease innovation and patient-centered commercial strategy. As Senior Vice President and Head of the Skeletal Conditions Business Unit at BioMarin, Michael leads global efforts to advance treatments for rare, progressive skeletal conditions, many of which disproportionately affect children. 

Michael Ash’s leadership is defined by a tireless pursuit of better outcomes for patients and communities affected by rare diseases. He is committed and focused on expanding access to life-changing treatments, fostering collaboration among industry stakeholders, and championing innovation both locally and globally. 

Educational and Professional Background

An Arizona native who grew up in Tucson, Michael earned his bachelor’s degree in business administration from the University of Arizona. His educational foundation provided a strong platform for his career in healthcare and biotechnology.

Michael’s professional career spans leadership roles at some of the industry’s leading biopharma organizations, including Genentech, Freenome, and BioMarin. Michael has spearheaded early diagnosis initiatives and cultivated partnerships with clinicians, researchers, and patient advocacy groups not only in Arizona but across more than 50 countries worldwide.

Board and Community Engagement

In addition to his executive responsibilities, Michael serves on the Board of Directors of BioMarin International, expanding his understanding of the global challenges faced by the rare disease community. His commitment to service is further demonstrated through prior roles, including serving on the Board of Directors for the Cancer Support Community AZ and active involvement in the University of Arizona Alumni Association.

Commitment to Arizona and Rare Disease Advocacy

Having called Arizona home for over thirty-five years, Michael is passionate about leveraging his expertise to serve his local community. He possesses a deep understanding of the unique challenges within the rare disease ecosystem, from delayed diagnoses to limited access to specialists. Michael is dedicated to improving the lives of individuals living with rare diseases in Arizona and is committed to ensuring that the state remains at the forefront of healthcare innovation.

 

LinkedIn:  https://www.linkedin.com/in/michaelash415 /